Vaccines for Alzheimer’s: exploiting similarities with Down syndrome
One approach to overcome continuing challenges facing drug research and development for Alzheimer’s is a vaccine. Swiss AC Immune has...
Focus:
One approach to overcome continuing challenges facing drug research and development for Alzheimer’s is a vaccine. Swiss AC Immune has...
Expert commentary & analysis from GlobalData
Alopecia Areata market set to be worth $1.7bn by 2028 driven by the launch of JAK inhibitors, says GlobalData
Infectious diseases on Twitter: Ebola leads mentions in August 2019
Metabolic disorders on Twitter: Diabetes leads mentions in August 2019
Pfizer’s Upjohn and Mylan merger set to create drug and manufacturing juggernaut
Most Read
Company releases
Circular Screener for Calcium Carbonate
Pharmaceutical chalk is processed through the Finex 22™ with ultrasonic technology to prevent blockage, which increases production speeds.
CPL to Appear at 2019 Contract Pharma and Outsourcing Meeting, 26-27 September
FPS Proposes the Third workshop on Containment World in Rome
Taking place in Rome on 4 October, upon conclusion of the 5th edition of the HPAPI Summit, FPS will be...
New Non-Interventional Clinical Trials Legislation in Greece
GEHC and NIBRT to Enhance Talent Growth in Single-Use Bioprocessing
GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin,...
Company whitepapers
Improving the Safety and Efficiency of the Pharmaceutical Manufacturing Process
ILC DoverDetermination of Absorption of Isopropyl Myristate in Processing Equipment and Packaging Material by Liquid Extraction and Gas Chromatography
CPLCreative Pharma Services Brochure
Creative Pharma ServicesHelping to Build a Smarter Diagnostic Assay
GE Healthcare Life SciencesThermal Shipping Technologies: The Cold Hard Facts
TemptimeThe Antibody Dependent Cell Mediated Cytotoxicity
BioassayChoosing a Single-Use Flexible Containment System
ILC DoverCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Pfizer’s Gene Therapy Manufacturing Facility Expansion, North Carolina
Pfizer, a pharmaceutical company based in the US, is expanding its gene therapy manufacturing facility located at Sanford campus in North Carolina, US.
Vaccines Manufacturing Innovation Centre, Oxfordshire
Mapi Pharma’s Sterile Injectable Production Plant in Jerusalem
Eisai’s New Oral Solid Dose Production Facility, Suzhou
Eli Lilly’s New Bio Manufacturing Plant, Cork
Clinical Trials
Novartis presents additional Zolgensma data in children with SMA
Novartis subsidiary AveXis has announced interim data for Zolgensma (onasemnogene abeparvovec-xioi) in children with spinal muscular atrophy (SMA) type 1, the most severe form of...
Versantis raises funds to advance liver disease drugs
FDA approves Keytruda plus Lenvima for endometrial carcinoma
Biogen and Eisai discontinue Alzheimer’s trials of BACE inhibitor
Inotrem secures funds to develop septic shock treatment
Design
USPTO reverses decision regarding interfering CRISPR patents
The Patient Trial and Appeal Board (PTAB) of the US Patent and Trademark Office (USPTO) has changed its stance regarding an interference between ten patent...
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
ProAmpac updates child-resistant pouch product line
Drug Development
Researchers use three-drug combination to treat lung cancer
A study by the Francis Crick Institute and The Institute of Cancer Research, London has tested the combination of a G12C KRAS inhibitor with mTOR...
AstraZeneca revises Linzess deal with Ironwood Pharmaceuticals
Amplyx licences Phase II anti-viral candidate from Novartis
Biogen and Eisai discontinue Alzheimer’s trials of BACE inhibitor
Inotrem secures funds to develop septic shock treatment
Market Data
Purdue Pharma files for bankruptcy to support opioid case settlement
Opioid drugs manufacturer Purdue Pharma has filed for Chapter 11 bankruptcy to settle more than 2,000 lawsuits, which claim the company contributed to the opioid...
Novo Nordisk to provide discounted insulin products in US
UK’s NICE recommends Novartis’ Luxturna gene therapy for rare eye disease
J&J ordered to pay $572m in Oklahoma opioid lawsuit
UK to set up freight service for medicines supply post Brexit
Technology
Atomwise inks four new deals for AI-based drug discovery
US-based Atomwise has formed four new alliances to leverage its artificial intelligence (AI) technology for the discovery of new drugs across various therapeutic areas.
Gene therapy biotech Genenta raises €13.2m in funding round
AZ licenses PARPi to Theragnostics to develop novel radiopharmaceuticals
Insilico Medicine develops new AI drug discovery system
Mateon and PointR to merge into AI-driven oncology firm
kinaxis: Your recommended content
Challenges for the life sciences supply chain with Brexit
DJA: Your recommended content
Electrolab: Pharmaceutical testing equipment
How Electronic Inspection Sensors Prevented A Potentially Extremely Costly Product Recall
View whitepaper
NSF Pharma: Your recommended content
Pharmaceutical consulting: How outside experts can improve your processes
Six essential ways to improve your pharmaceutical quality system
View whitepaper
ILC Dover: Your recommended content
How CMO/CDMO facilities can gain value with single use containment
Choosing Single-Use Flexible Containment Systems For Charging And Offloading Transfer Operations
View whitepaper
Hapa: Your recommended content
The Ferrari of medical machinery: How one solution impressed Arimpek
Process For Low Migration Qualification In The Food, Pharma And Medical Industry
View whitepaper
Medel Pharm: Your recommended content
Innovative technologies in tabletting development
Go Top